Literature DB >> 9143566

Antibiotic prophylaxis for pit viper envenomation: prospective, controlled trial.

K R Kerrigan1, B L Mertz, S J Nelson, J D Dye.   

Abstract

The efficacy of prophylactic antibiotics for preventing infectious complications at the site of pit viper envenomation has not been well studied. We undertook a prospective, controlled trial of antibiotic treatment versus no antibiotic treatment among 114 victims of crotalid envenomation in Ecuador's Amazon rain forest. A group of 59 patients received intravenous gentamicin and chloramphenicol, and 55 patients did not. All other aspects of care were identical. There were no statistically significant differences between antibiotic-treated and untreated patients with regard to demographics, delay in treatment, clinical and laboratory evidence of severity of envenomation, or use of antivenin. Nine abscesses occurred, six in the antibiotic-treated group and three in the untreated group. The results of this study did not show any statistically significant differences in outcome in terms of the number of abscesses that occurred between antibiotic-treated and untreated patients. Based on this lack of differences, routine use of prophylactic antibiotics for prevention of infectious complications of crotalid envenomation cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143566     DOI: 10.1007/pl00012255

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  8 in total

Review 1.  Microbiology of animal bite wound infections.

Authors:  Fredrick M Abrahamian; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Serum Procalcitonin Concentration and Its Relationship with Local Manifestations after Snakebites.

Authors:  Chanaveerappa Bammigatti; Preetham A Reddy; Nandeesha Hanumanthappa; K T Harichandrakumar; Rathinam Palamalai Swaminathan
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

3.  Bacteriology of Naja atra Snakebite Wound and Its Implications for Antibiotic Therapy.

Authors:  Yan-Chiao Mao; Po-Yu Liu; Dong-Zong Hung; Wei-Cheng Lai; Shih-Ting Huang; Yao-Min Hung; Chen-Chang Yang
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

4.  Documentation of a proven Mountain Pitviper (Ovophis monticola) envenomation in Kathmandu, Nepal, with its distribution ranges: implications for prevention and control of pitviper bites in Asia.

Authors:  Deb Prasad Pandey; Budhan Chaudhary; Bhola Ram Shrestha
Journal:  J Venom Res       Date:  2021-01-06

5.  Terrestrial snakebites in the South East of the Arabian Peninsula: patient characteristics, clinical presentations, and management.

Authors:  Juma M Alkaabi; Mariam Al Neyadi; Fakhra Al Darei; Mariam Al Mazrooei; Jawaher Al Yazedi; Abdishakur M Abdulle
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

6.  Routine prophylactic antibiotic use in the management of snakebite.

Authors:  D D Tagwireyi; D E Ball; C F Nhachi
Journal:  BMC Clin Pharmacol       Date:  2001-11-02

7.  Poor efficacy of preemptive amoxicillin clavulanate for preventing secondary infection from Bothrops snakebites in the Brazilian Amazon: A randomized controlled clinical trial.

Authors:  Jacqueline A G Sachett; Iran Mendonça da Silva; Eliane Campos Alves; Sâmella S Oliveira; Vanderson S Sampaio; Fábio Francesconi do Vale; Gustavo Adolfo Sierra Romero; Marcelo Cordeiro Dos Santos; Hedylamar Oliveira Marques; Mônica Colombini; Ana Maria Moura da Silva; Fan Hui Wen; Marcus V G Lacerda; Wuelton M Monteiro; Luiz C L Ferreira
Journal:  PLoS Negl Trop Dis       Date:  2017-07-10

8.  An investigation of conventional microbial culture for the Naja atra bite wound, and the comparison between culture-based 16S Sanger sequencing and 16S metagenomics of the snake oropharyngeal bacterial microbiota.

Authors:  Yan-Chiao Mao; Han-Ni Chuang; Chien-Hung Shih; Han-Hsueh Hsieh; Yu-Han Jiang; Liao-Chun Chiang; Wen-Loung Lin; Tzu-Hung Hsiao; Po-Yu Liu
Journal:  PLoS Negl Trop Dis       Date:  2021-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.